Jones Financial Companies
PCRX icon

Jones Financial Companies’s Pacira BioSciences PCRX Stock Holding History

Jones Financial Companies’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
7,279
-9,459
-57% -$224K ﹤0.01% 2617
2026
Q1 		$383K Buy
16,738
+14,728
+733% +$327K ﹤0.01% 2157
2025
Q4 		$52K Buy
2,010
+1,995
+13,300% +$47.4K ﹤0.01% 2501
2025
Q3 		$379 Hold
15
– – ﹤0.01% 4072
2025
Q2 		$352 Buy
+15
New +$378 ﹤0.01% 3856

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's PCRX Position: Q2 2026 in Review

Jones Financial Companies reduced its Pacira BioSciences (PCRX) stake by 57% in Q2 2026, selling an estimated $224K and leaving 7,279 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Jones Financial Companies first reported a position in PCRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $383K in Q1 2026. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Jones Financial Companies held 7,279 shares of Pacira BioSciences worth $184K as of Q2 2026.
  • Jones Financial Companies sold 9,459 Pacira BioSciences shares in Q2 2026, an estimated $224K.
  • Pacira BioSciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2617 holding.
  • Jones Financial Companies first reported a position in Pacira BioSciences in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Pacira BioSciences position peaked at $383K in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.